Sequential treatment with Nab-paclitaxel plus Gemcitabine and Folfirinox in metastatic pancreatic adenocarcinoma: GABRINOX phase II results.
2018
4109Background: Folfirinox (FFX) and Nab-paclitaxel/Gemcitabine (AG) showed significant efficacy improvement compared to Gemcitabine alone in metastatic pancreatic cancer (mPC). Alternating AG and ...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
7
Citations
NaN
KQI